Efficacy and safety of FOLFIRI and biotherapy versus FOLFIRI alone for metastatic colorectal cancer patients: A meta-analysis

BACKGROUND: Previous randomized controlled trials (RCTs) and meta-analyses have demonstrated the useless of FOLFIRI alone for previously treated patients with metastatic colorectal cancer (mCRC). The role of FOLFIRI regimen combined with biological therapy is unknown. The purpose of this meta-analys...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yangbo, Fan, Hui, Jiang, Yongmei, Song, Guirong, Wang, Feng, Li, Xiaofeng, Li, Guoquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
6800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728752/
https://www.ncbi.nlm.nih.gov/pubmed/29310351
http://dx.doi.org/10.1097/MD.0000000000008767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728752/
https://www.ncbi.nlm.nih.gov/pubmed/29310351
http://dx.doi.org/10.1097/MD.0000000000008767

Ejemplares similares